Your browser doesn't support javascript.
loading
Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Otsuki, Yuji; Yamasaki, Juntaro; Suina, Kentaro; Okazaki, Shogo; Koike, Naoyoshi; Saya, Hideyuki; Nagano, Osamu.
Affiliation
  • Otsuki Y; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Yamasaki J; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Suina K; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Okazaki S; Division of Development and Aging, Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Japan.
  • Koike N; Department of Radiology, Keio University School of Medicine, Tokyo, Japan.
  • Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Nagano O; Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Cancer Sci ; 111(1): 127-136, 2020 Jan.
Article in En | MEDLINE | ID: mdl-31692172

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxyfedrine / Vasodilator Agents / Amino Acid Transport System y/ / Aldehydes / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxyfedrine / Vasodilator Agents / Amino Acid Transport System y/ / Aldehydes / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2020 Document type: Article Affiliation country: Japan